Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > 4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline hydrochloride
4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline hydrochloride structure, CAS 184475-55-6

4-(3-Chloro-4-fluorophenylamino)-7-methoxy-6-[3-(4-morpholinyl)propoxy]quinazoline hydrochloride

CAS Number184475-55-6

SynonymsGefitinib hydrochloride salt; 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline hydrochloride salt; X5007; Gefitinib hydrochloride; Gefitinib (hydrochloride)

Molecular FormulaC22H25Cl2FN4O3

Molecular Weight483.363

Purity98%%

Density

Boiling Point607.7ºC at 760 mmHg

Melting Point

Flash Point

Appearancepowder

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-1171182 Purity: 98%%
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Quality Control of [ 184475-55-6 ] Purity: 98%% SDS Specification MoL

Chemical & Physical Properties
CAS Number184475-55-6
Catalog No.2A-1171182
Chinese NameGefitinib hydrochloride
SynonymsGefitinib hydrochloride salt; 4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline hydrochloride salt; X5007; Gefitinib hydrochloride; Gefitinib (hydrochloride)
Molecular FormulaC22H25Cl2FN4O3
Molecular Weight483.363
Purity98%
Boiling Point607.7ºC at 760 mmHg
Appearancepowder
Storage Condition-20℃
ApplicationGefitinib hydrochloride is a potent EGFR tyrosine kinase inhibitor with IC50 values ​​of 2-37 nM in NR6wtEGFR cells.
PubChem ID31643822
SMILESCOc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1.Cl
InChIInChI=1S/C22H24ClFN4O3.ClH/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15;/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27);1H
InChI KeyQUINXWLATMJDQF-UHFFFAOYSA-N
Transport InfoProduct name: Gefitinib hydrochloride
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA